Obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group: Consumption of a capsule containing 30 mg zinc gluconate (manufactured by nature made) per day for 3 months. Intervention 2: Control group: Consumption of a capsule
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 55 Years
Inclusion criteria
Inclusion criteria: BMI> 30 kg/m2 Serum zinc 20
Exclusion criteria
Exclusion criteria: Vitamin and supplements use over the past 2 months Diet or weight loss products use recently Presence of liver, kidney, thyroid, diabetes, AIDS and other metabolic diseases Using lipid lowering, blood-thinning and beta-blocker drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of leptin. Timepoint: At entry and 3 month after zinc supplementation. Method of measurement: ELISA method.;Serum level of ghrelin. Timepoint: At entry and 3 month after zinc supplementation. Method of measurement: ELISA method.;Serum level of C-Reactive Protein (CRP). Timepoint: At entry and 3 month after zinc supplementation. Method of measurement: Immunoturbidimetric method.;Serum zinc consentration. Timepoint: At entry and 3 month after zinc supplementation. Method of measurement: Atomic absorption spectrometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index (BMI). Timepoint: At entry, week 6 and 3 month after zinc supplementation. Method of measurement: Weight in Kilograms divided by height in metres squared.;Waist to Hip Ratio (WHR). Timepoint: At entry, week 6 and 3 month after zinc supplementation. Method of measurement: Waist circumference divided by hip circemference. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarjes Zare
Shiraz University of Medical Sciences
Outcome results
None listed